Congenital pneumonia due to streptococcus, group B
ICD-10 P23.3 is a billable code used to indicate a diagnosis of congenital pneumonia due to streptococcus, group b.
Congenital pneumonia due to Group B Streptococcus (GBS) is a significant cause of neonatal morbidity and mortality. This condition arises when the bacteria are transmitted from the mother to the fetus during pregnancy or delivery, leading to infection in the newborn. GBS can colonize the maternal genital tract and, if present, can infect the newborn either in utero or during passage through the birth canal. Clinical manifestations of congenital pneumonia may include respiratory distress, tachypnea, grunting, and cyanosis shortly after birth. Diagnosis is typically confirmed through clinical evaluation and laboratory tests, including blood cultures and chest X-rays. Early recognition and treatment are crucial, as untreated GBS pneumonia can lead to severe complications, including sepsis and long-term neurological impairment. Management often involves the administration of intravenous antibiotics and supportive care in a neonatal intensive care unit (NICU).
Detailed documentation of respiratory assessment, maternal history, and treatment protocols.
Newborn presenting with respiratory distress shortly after birth, requiring NICU admission for management.
Consideration of other potential causes of pneumonia and the need for timely intervention.
Comprehensive history including maternal health, delivery details, and newborn assessment.
Follow-up visits for newborns with a history of GBS pneumonia, monitoring for long-term effects.
Awareness of potential developmental delays or complications stemming from early infection.
Used when a newborn with congenital pneumonia is evaluated in the NICU.
Document the clinical assessment, treatment plan, and any interventions performed.
Neonatologists should ensure comprehensive documentation of respiratory assessments.
Maternal GBS screening is crucial as it helps identify mothers at risk of transmitting the bacteria to their newborns, allowing for timely antibiotic prophylaxis during labor to reduce the incidence of congenital pneumonia.